Source Post

Oscar Health ($OSCR) MLR And Novo Nordisk ($NVO) Overreaction

Aug 1, 2026

The creator discusses Oscar Health (OSCR) and Novo Nordisk (NVO). For Oscar Health, the focus is on their upcoming Q2 earnings, with expectations for strong revenue growth and a potential increase in the medical loss ratio. The creator highlights that the stock's valuation is sensitive to margin expansion, suggesting a potential doubling if margins reach 5%. For Novo Nordisk, the stock fell due to an announcement unrelated to earnings, and the creator plans to analyze its impact.

Linked Mentions

Tickers discussed in this post

UNHNeutralLow ConvictionResearch Only

UnitedHealth Group is mentioned as a healthcare play that has performed well, up 42%.

ADBEBullishMedium ConvictionSignal-backedSecondary

Adobe has run up recently but is still below all-time highs and could be another winner over the next 12-18 months.

METABullishHigh ConvictionSignal-backedPrimary

Meta is considered the weakest of the three software picks but is expected to reach over $1000 in the next 5 years.

NOWBullishMedium ConvictionSignal-backedSecondary

ServiceNow is highlighted as a potential software winner over the next 12-18 months.

MSFTBullishMedium ConvictionSignal-backedSecondary

Microsoft is identified as a potential winner in the software space over the next 12-18 months.

NVONeutralLow ConvictionSignal-backedSecondary

Novo Nordisk (NVO) experienced a nearly 10% stock price drop following an announcement unrelated to earnings, prompting an analysis of the news's impact and analyst reactions.

OSCRNeutralMedium ConvictionSignal-backedPrimary

Oscar Health (OSCR) is approaching Q2 earnings with strong revenue growth expected, but the medical loss ratio's impact on margins is key to its valuation, with potential for the stock to double if margins reach 5%.

Linked Signals

Tracked calls opened from this post

META
buy opened Aug 1, 2026
+2.81%